Shares in Optiscan Imaging (ASX:OIL) have surged more than 170 per cent over the last year as the commercial stage medical technology company advances its suite of digital pathology and precision surgery hardware and software solutions. Optiscan is focused on the development, manufacturing, and commercialisation of imaging technologies for medical, translational and pre-clinical applications. Ahead of appearing at the Stocks On Track event in Melbourne, Optiscan Imaging’s CEO and Managing Director, Dr Camile Farah speaks with The Stock Network’s Lel Smits.
1 FY24 Strategy milestones
Optiscan realised a host of development strategy milestones during its 2024 financial year (FY24). What were the biggest milestones achieved over this 12-month period and what makes them so significant?
2 Operational and addressable markets focus
What is Optiscan’s current focus from both an operational and addressable markets perspective and what are the key catalysts for the year ahead?
3 FY25 outlook
How would you like to see the company positioned in a year from now?
_ _ _
Subscribe to TSN’s YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1
_ _ _
Follow TSN for the latest stock news and interviews:
Twitter: https://twitter.com/thestocknet
Instagram: https://www.instagram.com/thestocknetwork/
LinkedIn: https://www.linkedin.com/company/the-stock-network/
TikTok: https://www.tiktok.com/@thestocknet?lang=en
Facebook: https://www.facebook.com/TheStockNet/
_ _ _
Connect with our host Lel Smits online – @LelSmits
– Twitter / X: https://twitter.com/lelsmits
– Instagram: https://www.instagram.com/lelsmits/
– LinkedIn: https://www.linkedin.com/in/leldesmits/
– TikTok: https://www.tiktok.com/@lelsmits?lang=en
– Facebook: https://m.facebook.com/lelsmits/
– Threads: https://www.threads.net/@lelsmits
_ _ _
Disclaimer
The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss.
This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer.
_ _ _
Visit TSN’s website to sign up for regular stock updates: https://www.thestocknetwork.com.au
_ _ _